408 related articles for article (PubMed ID: 34833991)
1. Curcumin Inhibits In Vitro SARS-CoV-2 Infection In Vero E6 Cells through Multiple Antiviral Mechanisms.
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Flórez-Álvarez L; Yepes LM; Rugeles MT; Zapata-Builes W; Hernandez JC; Taborda NA
Molecules; 2021 Nov; 26(22):. PubMed ID: 34833991
[TBL] [Abstract][Full Text] [Related]
2. Optimization of Anti-SARS-CoV-2 Treatments Based on Curcumin, Used Alone or Employed as a Photosensitizer.
Zupin L; Fontana F; Clemente L; Borelli V; Ricci G; Ruscio M; Crovella S
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298687
[TBL] [Abstract][Full Text] [Related]
3. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
[TBL] [Abstract][Full Text] [Related]
4. Broad-Spectrum Antiviral Activity of 3D8, a Nucleic Acid-Hydrolyzing Single-Chain Variable Fragment (scFv), Targeting SARS-CoV-2 and Multiple Coronaviruses In Vitro.
Lee G; Budhathoki S; Lee GY; Oh KJ; Ham YK; Kim YJ; Lim YR; Hoang PT; Lee Y; Lim SW; Kim JM; Cho S; Kim TH; Song JW; Lee S; Kim WK
Viruses; 2021 Apr; 13(4):. PubMed ID: 33918914
[TBL] [Abstract][Full Text] [Related]
5. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
[TBL] [Abstract][Full Text] [Related]
6. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
7. PM10 promotes an inflammatory cytokine response that may impact SARS-CoV-2 replication
Marín-Palma D; Tabares-Guevara JH; Zapata-Cardona MI; Zapata-Builes W; Taborda N; Rugeles MT; Hernandez JC
Front Immunol; 2023; 14():1161135. PubMed ID: 37180105
[TBL] [Abstract][Full Text] [Related]
8. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
9. Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro.
Bormann M; Alt M; Schipper L; van de Sand L; Le-Trilling VTK; Rink L; Heinen N; Madel RJ; Otte M; Wuensch K; Heilingloh CS; Mueller T; Dittmer U; Elsner C; Pfaender S; Trilling M; Witzke O; Krawczyk A
Viruses; 2021 Sep; 13(10):. PubMed ID: 34696344
[TBL] [Abstract][Full Text] [Related]
10. Antiviral, anti-inflammatory and antioxidant effects of curcumin and curcuminoids in SH-SY5Y cells infected by SARS-CoV-2.
Nicoliche T; Bartolomeo CS; Lemes RMR; Pereira GC; Nunes TA; Oliveira RB; Nicastro ALM; Soares ÉN; da Cunha Lima BF; Rodrigues BM; Maricato JT; Okuda LH; de Sairre MI; Prado CM; Ureshino RP; Stilhano RS
Sci Rep; 2024 May; 14(1):10696. PubMed ID: 38730068
[TBL] [Abstract][Full Text] [Related]
11. Gallium maltolate has
Bernstein LR; Zhang L
Antivir Chem Chemother; 2020; 28():2040206620983780. PubMed ID: 33353394
[TBL] [Abstract][Full Text] [Related]
12. Application of Copper Iodide Nanoparticle-Doped Film and Fabric To Inactivate SARS-CoV-2 via the Virucidal Activity of Cuprous Ions (Cu
Takeda Y; Jamsransuren D; Nagao T; Fukui Y; Matsuda S; Ogawa H
Appl Environ Microbiol; 2021 Nov; 87(24):e0182421. PubMed ID: 34613751
[TBL] [Abstract][Full Text] [Related]
13. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
Maestro S; Córdoba KM; Olague C; Argemi J; Ávila MA; González-Aseguinolaza G; Smerdou C; Fontanellas A
Biomed Pharmacother; 2021 May; 137():111384. PubMed ID: 33761605
[TBL] [Abstract][Full Text] [Related]
14. 17β-estradiol reduces SARS-CoV-2 infection in vitro.
Lemes RMR; Costa AJ; Bartolomeo CS; Bassani TB; Nishino MS; Pereira GJDS; Smaili SS; Maciel RMB; Braconi CT; da Cruz EF; Ramirez AL; Maricatto JT; Janini LMR; Prado CM; Stilhano RS; Ureshino RP
Physiol Rep; 2021 Jan; 9(2):e14707. PubMed ID: 33463909
[TBL] [Abstract][Full Text] [Related]
15. The
Urda L; Kreuter MH; Drewe J; Boonen G; Butterweck V; Klimkait T
Viruses; 2022 Jan; 14(1):. PubMed ID: 35062310
[TBL] [Abstract][Full Text] [Related]
16. Antiviral activity of oleandrin and a defined extract of Nerium oleander against SARS-CoV-2.
Plante KS; Dwivedi V; Plante JA; Fernandez D; Mirchandani D; Bopp N; Aguilar PV; Park JG; Tamayo PP; Delgado J; Shivanna V; Torrelles JB; Martinez-Sobrido L; Matos R; Weaver SC; Sastry KJ; Newman RA
Biomed Pharmacother; 2021 Jun; 138():111457. PubMed ID: 33721754
[TBL] [Abstract][Full Text] [Related]
17. Quinacrine, an Antimalarial Drug with Strong Activity Inhibiting SARS-CoV-2 Viral Replication In Vitro.
Salas Rojas M; Silva Garcia R; Bini E; Pérez de la Cruz V; León Contreras JC; Hernández Pando R; Bastida Gonzalez F; Davila-Gonzalez E; Orozco Morales M; Gamboa Domínguez A; Sotelo J; Pineda B
Viruses; 2021 Jan; 13(1):. PubMed ID: 33477376
[TBL] [Abstract][Full Text] [Related]
18. Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms.
Malebari AM; E A Ahmed H; Ihmaid SK; Omar AM; Muhammad YA; Althagfan SS; Aljuhani N; A A El-Sayed AA; Halawa AH; El-Tahir HM; Turkistani SA; Almaghrabi M; K B Aljohani A; El-Agrody AM; Abulkhair HS
Bioorg Chem; 2023 Jan; 130():106255. PubMed ID: 36403336
[TBL] [Abstract][Full Text] [Related]
19. A novel film spray containing curcumin inhibits SARS-CoV-2 and influenza virus infection and enhances mucosal immunity.
Nittayananta W; Lerdsamran H; Chutiwitoonchai N; Promsong A; Srichana T; Netsomboon K; Prasertsopon J; Kerdto J
Virol J; 2024 Jan; 21(1):26. PubMed ID: 38263162
[TBL] [Abstract][Full Text] [Related]
20. Niclosamide shows strong antiviral activity in a human airway model of SARS-CoV-2 infection and a conserved potency against the Alpha (B.1.1.7), Beta (B.1.351) and Delta variant (B.1.617.2).
Weiss A; Touret F; Baronti C; Gilles M; Hoen B; Nougairède A; de Lamballerie X; Sommer MOA
PLoS One; 2021; 16(12):e0260958. PubMed ID: 34855904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
